(Q81098313)

English

Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage

scientific article published on 03 August 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

pregnant person

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

4

object named as

Hanna Nohynek

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

5

object named as

Helena Käyhty

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Emma Holmlund

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Beatriz Quiambao

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

3 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

57-65

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Pneumococcal vaccines: history, current status, and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Antibody response to pneumococcal vaccination in children younger than five years of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Natural materno-fetal transfer of antibodies to PspA and to PsaA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Pneumococcal carriage in children during their first two years: important role of family exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

The development of the bacterial flora in normal neonates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Human antibodies to pneumococcal surface protein A in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Protection against bacteremic pneumococcal infection by antibody to pneumolysin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Half-life of the maternal IgG1 allotype in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

The immune response to pneumococcal proteins during experimental human carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.055

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.07.055

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16115703%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81098313&oldid=2234983232"